search
Back to results

Sepsis, Severe Sepsis and Septic Shock Detection by Breath Analysis

Primary Purpose

Sepsis

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Breath sample collection
Sponsored by
Landon Pediatric Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Sepsis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • admitted to Emergency Department
  • suspected of sepsis according to hospital screening criteria; point of care blood lactate test performed
  • age 18 or older

Exclusion Criteria:

  • member of Vulnerable Patient Population
  • unable to complete Patient Informed Consent process/document

Sites / Locations

  • Ventura County Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Breath sample collection

Arm Description

Outcomes

Primary Outcome Measures

Volatile Organic Compound (VOC) Pattern
Detection of a unique pattern of Volatile Organic Compounds (VOCs) in the breath samples of patients confirmed as having sepsis/severe sepsis/septic shock differentiated from subjects confirmed as not septic.

Secondary Outcome Measures

Full Information

First Posted
April 6, 2018
Last Updated
May 3, 2019
Sponsor
Landon Pediatric Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT03497182
Brief Title
Sepsis, Severe Sepsis and Septic Shock Detection by Breath Analysis
Official Title
Study to Assess Feasibility of Sepsis, Severe Sepsis and Septic Shock Detection by Breath Analysis
Study Type
Interventional

2. Study Status

Record Verification Date
May 2019
Overall Recruitment Status
Completed
Study Start Date
May 2, 2017 (Actual)
Primary Completion Date
October 6, 2018 (Actual)
Study Completion Date
October 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Landon Pediatric Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Breath samples will be collected from patients suspected of sepsis/severe sepsis or septic shock according to hospital sepsis screening criteria in the Emergency Department.
Detailed Description
Breath samples will be collected from patients suspected of sepsis that meet the criteria in the hospital's Sepsis Patient Management Protocol for blood lactate point of care testing. The breath samples will be collected from the patient by the Respiratory Therapist (RT) at the time of blood sample collection for the blood lactate test. The breath samples will be analyzed via gas chromatography-surface acoustic wave spectroscopy for detection of a pattern of volatile organic compounds (VOCs). Multivariate analysis will be performed on breath sample data to determine feasibility of associating a unique VOC pattern with septic/severe septic/septic shock patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sepsis

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
45 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Breath sample collection
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Breath sample collection
Intervention Description
Subject exhales into breath collection container.
Primary Outcome Measure Information:
Title
Volatile Organic Compound (VOC) Pattern
Description
Detection of a unique pattern of Volatile Organic Compounds (VOCs) in the breath samples of patients confirmed as having sepsis/severe sepsis/septic shock differentiated from subjects confirmed as not septic.
Time Frame
five minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: admitted to Emergency Department suspected of sepsis according to hospital screening criteria; point of care blood lactate test performed age 18 or older Exclusion Criteria: member of Vulnerable Patient Population unable to complete Patient Informed Consent process/document
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chris Landon
Organizational Affiliation
Director Pediatrics
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ventura County Medical Center
City
Ventura
State/Province
California
ZIP/Postal Code
93003
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Sepsis, Severe Sepsis and Septic Shock Detection by Breath Analysis

We'll reach out to this number within 24 hrs